Orphenadrine Extended-Release Tablets and Sodium phenylbutyrate
Determining the interaction of Orphenadrine Extended-Release Tablets and Sodium phenylbutyrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Sodium Phenylbutyrate Powder
- Orphenadrine Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Orphenadrine Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Orphenadrine Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Orphenadrine Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Orphenadrine Extended-Release Tablets-Sodium Phosphates
- Sodium phenylbutyrate-Orphenadrine Injection
- Sodium phenylbutyrate-Orphenadrine w/A.C.
- Sodium phenylbutyrate-Orphenadrine, aspirin, and caffeine
- Sodium phenylbutyrate-Orphenate
- Sodium phenylbutyrate-Orphengesic
- Sodium phenylbutyrate-Orphengesic Forte